Glucagon receptor antagonists, preparation and therapeutic uses
申请人:Eli Lilly & Company
公开号:EP2159221A1
公开(公告)日:2010-03-03
The present invention discloses novel compounds of Formula I, or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using these compounds and compositions to treat diabetic and other glucagon related metabolic disorders, and the like.
本发明公开了具有胰高血糖素受体拮抗剂或反向激动剂活性的新型式 I 化合物或其药学上可接受的盐,以及制备此类化合物的方法。在另一个实施方案中,本发明公开了包含式 I 化合物的药物组合物,以及使用这些化合物和组合物治疗糖尿病和其他胰高血糖素相关代谢紊乱等疾病的方法。
Decarboxylative Intramolecular Arene Alkylation Using <i>N</i>-(Acyloxy)phthalimides, an Organic Photocatalyst, and Visible Light
作者:Trevor C. Sherwood、Hai-Yun Xiao、Roshan G. Bhaskar、Eric M. Simmons、Serge Zaretsky、Martin P. Rauch、Robert R. Knowles、T. G. Murali Dhar
DOI:10.1021/acs.joc.9b00432
日期:2019.7.5
An intramolecular arene alkylation reaction has been developed using the organic photocatalyst 4CzIPN, visible light, and N-(acyloxy)phthalimides as radical precursors. Reaction conditions were optimized via high-throughput experimentation, and electron-rich and electron-deficient arenes and heteroarenes are viable reaction substrates. This reaction enables access to a diverse set of fused, partially